Literature DB >> 3315701

In vitro production of human interleukin 1 alpha and interleukin 1 beta by peripheral blood mononuclear cells examined by sensitive sandwich enzyme immunoassay.

K Tanaka1, E Ishikawa, Y Ohmoto, Y Hirai.   

Abstract

The in vitro production of human interleukin 1 alpha (hIL 1 alpha) and interleukin 1 beta (hIL 1 beta) by peripheral blood mononuclear cells was examined by sensitive sandwich enzyme immunoassays which could discriminate hIL 1 alpha and hIL 1 beta without cross-reaction with human IL2. In culture supernatants of mononuclear cells, two components were detected by sandwich enzyme immunoassay for hIL 1 alpha or hIL 1 beta. The molecular weight of one component was shown to be equal to that of recombinant hIL 1 alpha or hIL 1 beta by gel filtration. The elution volume of the other component corresponded to a molecular weight of about 30,000. The sum of the two components for both hIL 1 alpha and hIL 1 beta in culture supernatants of peripheral blood mononuclear cells from healthy subjects increased 1.7 to 38-fold by Escherichia coli lipopolysaccharide. The sum of the two components for hIL 1 beta was 13 to 97-fold larger than that for hIL 1 alpha.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3315701     DOI: 10.1002/eji.1830171024

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  15 in total

1.  Daily variance of urinary excretion of AQP2 determined by sandwich ELISA method.

Authors:  Sei Sasaki; Yasukazu Ohmoto; Toyoki Mori; Fusako Iwata; Masahiro Muraguchi
Journal:  Clin Exp Nephrol       Date:  2011-12-10       Impact factor: 2.801

2.  Aberrant cytokine production from tenosynovium in dialysis associated amyloidosis.

Authors:  N Miyasaka; K Sato; Y Kitano; M Higaki; K Nishioka; K Ohta
Journal:  Ann Rheum Dis       Date:  1992-06       Impact factor: 19.103

3.  Effects of recombinant human IL-1 beta on production of prostaglandin E2, leukotriene B4, NAG, and superoxide by human synovial cells and chondrocytes.

Authors:  T Tawara; M Shingu; M Nobunaga; T Naono
Journal:  Inflammation       Date:  1991-04       Impact factor: 4.092

4.  Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone.

Authors:  G D Roodman; N Kurihara; Y Ohsaki; A Kukita; D Hosking; A Demulder; J F Smith; F R Singer
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

5.  Effect of protein kinase C inhibitor (H-7) and calmodulin antagonist (W-7) on pertussis toxin-induced IL-1 production by human adherent monocytes. Comparison with lipopolysaccharide as a stimulator of IL-1 production.

Authors:  H Taniguchi; T Sakano; T Hamasaki; H Kashiwa; K Ueda
Journal:  Immunology       Date:  1989-06       Impact factor: 7.397

6.  Monocyte activation in early onset rheumatoid arthritis.

Authors:  I Fujii; M Shingu; M Nobunaga
Journal:  Ann Rheum Dis       Date:  1990-07       Impact factor: 19.103

7.  Reduced IL-1 production in adolescents with mite antigen asthma in remission.

Authors:  T Noma; K Ichikawa; I Yoshizawa; K Aoki; Y Kawano; M Baba
Journal:  Clin Exp Immunol       Date:  1998-07       Impact factor: 4.330

8.  Direct and indirect effects of human interferon alpha on renal cell carcinoma: a new in vitro assay system for evaluating cytokine-mediated antitumor effects.

Authors:  H Matsuyama; S Yoshihiro; Y Ohmoto; N Yamamoto; K Naito
Journal:  Cancer Immunol Immunother       Date:  1993-07       Impact factor: 6.968

9.  Effects of interferon-gamma on cell differentiation and cytokine production of a human monoblast cell line, U937.

Authors:  T Ishizuka; I Hirata; M Adachi; F Kurimoto; T Hisada; K Dobashi; M Mori
Journal:  Inflammation       Date:  1995-12       Impact factor: 4.092

10.  IL-1 beta and TNF-alpha produced by peripheral blood mononuclear cells before and during interferon therapy in patients with chronic hepatitis C.

Authors:  Y Kishihara; J Hayashi; E Yoshimura; K Yamaji; K Nakashima; S Kashiwagi
Journal:  Dig Dis Sci       Date:  1996-02       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.